Email
Completed
Details updated to quote for their reorder- design changes needed
Sep 11, 2025 06:43 PM
Hi Jack,
Thanks for the updates! We will get our team to make these updates and send you back the quote once completed.
Thank you,
Andrew Hartmann
Business Development Manager
–
25020 Avenue Tibbitts
Valencia, CA 91355
–
D +1.661.567.0667
P +1.888.UTAK.LAB
F +1.661.294.9272
–
Book a Meeting with Me
https://calendly.com/ahartmann-utak/30min
utak.com
From: Jack Bent <Jack.Bent@ethos-labs.com>
Sent: Thursday, September 11, 2025 1:17 PM
To: Andrew Hartmann <ahartmann@utak.com>
Cc: Beth Hawes <Beth.Hawes@ethos-labs.com>; Rebekah Hoffrogge <Rebekah.Hoffrogge@ethos-labs.com>; Theresa Ruwe <Theresa.Ruwe@ethos-labs.com>; James Bourland <James.Bourland@ethos-labs.com>
Subject: Re: UTAK Vendor Review
Hi Andrew-
We met today to discuss our needs for next year. There are some minor changes to the QC mix that we would like to make.
1. We would like to remove (l)-9-Carboxy-11-nor-Delta-9-THC(THC-COOH) from both levels.
2. We would like to remove Morphine-3-B-D-Glucuronide from the low level.
3. In the low level we would like to change the morphine target value from 225ng/mL to 375mg/mL.
4. We would like to remove Morphine from the high level
5. In the high level we would like to change the Morphine-3-B-D-Glucuronide target value from 460 ng/mL to 1220ng/mL.
6. We would like to change our order quantity from 7 for each level to 5 for each level.
Once that is done and you send us an updated quote we will be ready to order.
Thank you for your help on this,
Jack Bent
Outcome: Quote Requested